Navigation Links
Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
Date:11/15/2007

or trials designed to assess the safety and effectiveness of cethromycin in CAP patients compared to Biaxin. Trial CL-06 enrolled patients from clinics in Europe, South America and Israel and Trial CL-05 enrolled patients from the United States, Canada and South Africa. In both trials, cethromycin was evaluated using a 300 mg once-daily oral dosing regimen compared to 250 mg twice-daily dosing for Biaxin, both over a seven-day course of therapy. Biaxin is an FDA-approved standard of care antibiotic currently indicated for the treatment of CAP.

The primary endpoint for both trials was the clinical cure rate at the test-of-cure visit (Day 14-21 post-initiation of dosing). The eligibility of patients for each trial was based on clinical signs and symptoms as well as chest X-ray results as evaluated by an independent radiologist. Extensive electrocardiogram and liver function test monitoring were incorporated into the study design in order to examine safety in these areas and add to the safety database established in previous cethromycin clinical trials.

Results of Trial CL-05

In Trial CL-05, cethromycin met all efficacy endpoints and demonstrated a favorable safety profile as outlined below:

  • Per protocol clinical cure rate (PPc)- cethromycin 94.0% (205/218) compared to Biaxin 93.8% (195/208) [-4.5, +5.1] (p>0.9999) PPc is defined as subjects who have completed the minimum required study medication, have confirmed clinical diagnosis of CAP supported by a positive chest X-ray and appropriate clinical signs/symptoms of CAP, and have had no other systemic antibacterial agents administered during or prior to the study period. Based on the 94.0% clinical cure rate for cethromycin being greater than 90%, a delta value of 10% or less on the lower bound and greater than zero on the upper bound [-4.5, +5.1] establishes non-inferiority. Under this analysis, the study met the clinical cure rate endpoint in the PPc population. Since p>0
    '/>"/>

Contact: Melanie Nimrodi
mnimrodi@mww.com
312-546-3508
MWW Group
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. Kaiser Permanente Achieves Climate Action Leader Status
3. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
4. LMS integrated obstetrics solution achieves general availability
5. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
6. Pharsight Achieves $7.3 Million in Quarterly Revenue
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
9. Medical Services International Maintains Pace in Second Quarter
10. CEOs Need an Advertising Check Up or Second Opinion
11. Trojan(R) Ranks U.S. Colleges and Universities in Second Annual Sexual Health Report Card
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial ... School of Medicine, variations of the adiponectin gene, which ... womans risk of developing breast cancer. This discovery is ... it could help experts develop a future genetic testing ...
... NEW YORK (April 25, 2008) -- Heart failure patients ... first to be implanted with the HeartMate II LVAS ... that helps weak hearts pump blood -- that has ... 21 for broad use as bridge to transplantation. As ...
... County Sees Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., ... of cases of Gonorrhea last year in Delaware County,the Pennsylvania ... of 15 and 24 be routinely screened for the,disease, as ... Gonorrhea grew to 921 in 2007 from 513,the year before., ...
... With an aggressive growth plan in,effect for 2008, YoNaturals ... big step in their expansion efforts with new,vending locations ... of 2006, YoNaturals has maintained a strong,dedication toward changing ... have experienced thus far is in large part due ...
... Winner Renee Zellweger ("Chicago") Reteams with Craig Zadan and Neil Meron, Executive ... Producers for the Sony Pictures Television Project, Based ... a Doctor,s Dramatic Quest to Develop the Lifesaving Breast Cancer ... Drug Herceptin ...
... The Lupus Foundation of,America joins a coalition of approximately ... on May 10. More than 1.5 million,Americans and at ... they struggle daily with the often-debilitating health,consequences of the ... of an unbalanced immune system that can become,destructive to ...
Cached Medicine News:Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 3Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 4Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Provides reliable suction for surgical cases with larger amounts of drainage....
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Medicine Products: